KALM Therapeutics is creating a new category called the Protect AND Soothe patch modality for irritated skin

Public source

Publisher name

Public post

Thank you MSN for recognizing the KALM Patch's disruptive potential in skin care. In an industry ripe for innovation, KALM Therapeutics is creating a new category - the…

Log in to read the full post

Company

KALM Therapeutics

The 1st Rx patch to Protect and Treat eczema and psoriasis.

Industry
Biotechnology Research
Company size
2–10 employees

About KALM Therapeutics

Pioneering a Breakthrough in Eczema and Psoriasis Treatment Kalm Therapeutics is developing the 1st Prescription Patch treatment for eczema and psoriasis. Protect and Treat The Kalm Patch will cover the affected skin, protecting it from scratching, infection and moisture loss; all of which are known disease drivers. In addition, our proprietary formulation delivers a continuous therapeutic dose to the epidermis over 24 hours, which will provide optimal efficacy. Our natural active ingredient is a proven safe, anti-inflammatory small molecule. This once-a-day patch will be a giant leap from harmful steroids and other topical creams, which provide no protection to the skin, require multiple doses per day, and deliver uneven dose levels to the epidermis.

See more

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.